Neurology

Alzheimers dementia brain puzzle drug therapy

2023 forecast: Alzheimer's drugs ignite health tech arms race

With lecanemab expected to enter the market next year, health tech companies are finding ways to decrease friction in the Alzheimer's treatment path.

Annie Burky Dec 21, 2022 5:00am

Illustration of two people shaking hands standing on money and a lightbulb

Where digital health investors plan to place their bets in 2023

Dec 2, 2022 7:00am

Biogen

Blues plans pass on including aducanumab on formulary

Aug 16, 2021 3:15pm

A neurologist reviews brain scans

CMS should act quickly on coverage for Biogen's Alzheimer's drug

Jun 7, 2021 4:00pm

virtual visit

SOC Telemed acquires acute care telehealth company for $194M

Apr 1, 2021 7:10am

a man sits in front of a television monitor and uses a video-based therapy program

COVID-19 pandemic accelerates use of tele-neurorehabilitation

Jan 26, 2021 10:21am